ABVC BioPharma Inc

NAS:ABVC (USA)  
$ 1.20 -0.03 (-2.48%) 11:09 PM EST
At Loss
P/B:
0.64
Market Cap:
$ 10.27M
Enterprise V:
$ 13.10M
Volume:
135.51K
Avg Vol (2M):
2.57M
Volume:
135.51K
At Loss
Avg Vol (2M):
2.57M

Business Description

Description
ABVC BioPharma Inc is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset 0.55
Debt-to-Equity 0.37
Debt-to-EBITDA -0.36
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.49
Distress
Grey
Safe
Beneish M-Score -2.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.98
9-Day RSI 36.71
14-Day RSI 41.58
6-1 Month Momentum % 21.77
12-1 Month Momentum % -76.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.47
Quick Ratio 0.47
Cash Ratio 0.11
Days Inventory 17.91
Days Sales Outstanding 287.26
Days Payable 1.71

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19
Shareholder Yield % -8.7

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 42.08
Operating Margin % -1270.37
Net Margin % -1660.35
FCF Margin % -570.77
ROE % -316.09
ROA % -107.66
ROIC % -99.8
ROC (Joel Greenblatt) % -304.27
ROCE % -153.17

Financials (Next Earnings Date:2024-03-31 Est.)

ABVC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ABVC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ABVC BioPharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.739
EPS (TTM) ($) -3.59
Beta 0.68
Volatility % 84.66
14-Day RSI 41.58
14-Day ATR ($) 0.085022
20-Day SMA ($) 1.28375
12-1 Month Momentum % -76.15
52-Week Range ($) 0.6739 - 9.6
Shares Outstanding (Mil) 8.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ABVC BioPharma Inc Filings

Filing Date Document Date Form
No Filing Data

ABVC BioPharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ABVC BioPharma Inc Frequently Asked Questions

What is ABVC BioPharma Inc(ABVC)'s stock price today?
The current price of ABVC is $1.20. The 52 week high of ABVC is $9.60 and 52 week low is $0.67.
When is next earnings date of ABVC BioPharma Inc(ABVC)?
The next earnings date of ABVC BioPharma Inc(ABVC) is 2024-03-31 Est..
Does ABVC BioPharma Inc(ABVC) pay dividends? If so, how much?
ABVC BioPharma Inc(ABVC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1